About
Inhaled Nitric Oxide Delivery Solutions
Innohale Therapeutics develops inhaled nitric oxide (iNO) delivery solutions for the treatment of respiratory conditions from many etiologies (including COVID-19) and severe lung infections. The technology produces iNO from ambient air, which improves treatment accuracy and reduces costs and logistics burden.
Identity
| Name | Innohale Therapeutics |
|---|---|
| Slug | innohale-therapeutics |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NveipQJDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Tel Aviv, Israel |
Web & social
| Website | http://innohale.com/ |
|---|---|
| https://www.linkedin.com/company/72710330 | |
| Twitter / X | https://twitter.com/InnohaleT |
| YouTube | https://www.youtube.com/channel/UChyGiP2tkBB1qgsk8ksdM5w |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife Support
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Equipment
Business models
B2B
Tags
cardiovascularrespiratorydeliverytherapeutics
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}